BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24806510)

  • 1. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM.
    Assi H; Espinosa J; Suprise S; Sofroniew M; Doherty R; Zamler D; Lowenstein PR; Castro MG
    PLoS One; 2014; 9(5):e96318. PubMed ID: 24806510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
    Cohen PA; Koski GK; Czerniecki BJ; Bunting KD; Fu XY; Wang Z; Zhang WJ; Carter CS; Awad M; Distel CA; Nagem H; Paustian CC; Johnson TD; Tisdale JF; Shu S
    Blood; 2008 Sep; 112(5):1832-43. PubMed ID: 18577706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
    Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
    Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
    Li HS; Liu C; Xiao Y; Chu F; Liang X; Peng W; Hu J; Neelapu SS; Sun SC; Hwu P; Watowich SS
    Sci Signal; 2016 Sep; 9(447):ra94. PubMed ID: 27678219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
    Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
    J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of bifunctional IL2-GMCSF in promoting dendritic cell activation in vitro in simulated tumor-induced immune suppression].
    Wen Q; Xiong W; Liu S; Zhou C; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1239-44. PubMed ID: 26403731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of dendritic cell differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit+ murine hematopoietic progenitor cells.
    Zhang Y; Mukaida N; Wang J; Harada A; Akiyama M; Matsushima K
    Blood; 1997 Dec; 90(12):4842-53. PubMed ID: 9389701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptor regulates mouse GM-CSF-derived dendritic cell differentiation in vitro.
    Zhong L; Yang Q; Xie W; Zhou J
    Mol Immunol; 2014 Jul; 60(1):32-43. PubMed ID: 24747959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity.
    Lunz JG; Specht SM; Murase N; Isse K; Demetris AJ
    Hepatology; 2007 Dec; 46(6):1946-59. PubMed ID: 17935227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells induced in the presence of GM-CSF and IL-5.
    Yi H; Zhang L; Zhen Y; He X; Zhao Y
    Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway.
    Rizzuti D; Ang M; Sokollik C; Wu T; Abdullah M; Greenfield L; Fattouh R; Reardon C; Tang M; Diao J; Schindler C; Cattral M; Jones NL
    J Innate Immun; 2015; 7(2):199-211. PubMed ID: 25412627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
    Lim SN; Kuhn S; Hyde E; Ronchese F
    J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
    Xiong W; Candolfi M; Liu C; Muhammad AK; Yagiz K; Puntel M; Moore PF; Avalos J; Young JD; Khan D; Donelson R; Pluhar GE; Ohlfest JR; Wawrowsky K; Lowenstein PR; Castro MG
    PLoS One; 2010 Jun; 5(6):e11074. PubMed ID: 20552015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of dendritic cells in vitro from murine fetal liver-derived lineage phenotype-negative c-kit(+) hematopoietic progenitor cells.
    Zhang Y; Wang Y; Ogata M; Hashimoto S; Onai N; Matsushima K
    Blood; 2000 Jan; 95(1):138-46. PubMed ID: 10607696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development.
    Li HS; Yang CY; Nallaparaju KC; Zhang H; Liu YJ; Goldrath AW; Watowich SS
    Blood; 2012 Nov; 120(22):4363-73. PubMed ID: 23033267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy.
    van de Laar L; Coffer PJ; Woltman AM
    Blood; 2012 Apr; 119(15):3383-93. PubMed ID: 22323450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.
    Mineharu Y; King GD; Muhammad AK; Bannykh S; Kroeger KM; Liu C; Lowenstein PR; Castro MG
    Clin Cancer Res; 2011 Jul; 17(14):4705-18. PubMed ID: 21632862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.